Crescita Therapeutics Inc. (TSX:CTX) agreed to acquire Assets of Occy Laboratory on June 20, 2024.The transaction was approved by the bankruptcy court, is subject only to customary closing conditions, and is expected to close thereafter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 CAD | -1.89% |
|
+18.18% | +6.12% |
1st Jan change | Capi. | |
---|---|---|
+6.12% | 73.81L | |
+55.55% | 82TCr | |
+39.13% | 63TCr | |
-6.83% | 35TCr | |
+17.15% | 32TCr | |
+7.09% | 29TCr | |
+13.43% | 24TCr | |
+0.90% | 22TCr | |
+13.43% | 22TCr | |
+7.87% | 17TCr |
- Stock Market
- Equities
- CTX Stock
- News Crescita Therapeutics Inc.
- Crescita Therapeutics Inc. agreed to acquire Assets of Occy Laboratory Inc.